TRUSCREEN SHARE PURCHASE PLAN DETAILS

Company Announcement 17 September 2018 TRUSCREEN SHARE PURCHASE PLAN DETAILS As previously announced to the market, cervical cancer technology company, TruScreen Limited (NZAX:TRU), will today open a Share Purchase Plan to eligible shareholders. The Share Purchase Plan (SPP) offer document and forms will be mailed to eligible shareholders today. Attached are: o Notice of Offer o SPP Booklet ENDS For more information visit www.truscreen.com or contact Martin Dillon, TruScreen Chief Executive Officer, email: martindillon@truscreen.com. About TruScreen: TruScreen's real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue. A sophisticated proprietary algorithm framework distinguishes between normal and abnormal (cancerous and precancerous) tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN). A Single Use Sensor (SUS) is used for each patient to protect against cross-infection. End CA:00323946 For:TRU Type:OFFER Time:2018-09-17 08:31:21